AL
GWPH

Airain Ltd’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Airain Ltd’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$1.35M Sell
13,469
-5,472
-29% -$589K 0.06% 350
2017
Q1 		$2.29M Buy
18,941
+7,634
+68% +$936K 0.11% 210
2016
Q4 		$1.26M Buy
+11,307
New +$1.36M 0.1% 195
2014
Q4 		– Sell
-2,792
Closed -$226K – 984
2014
Q3 		$226K Buy
+2,792
New +$247K 0.02% 651

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Airain Ltd's GWPH Position: Q2 2017 in Review

Airain Ltd reduced its GW Pharmaceuticals Plc American Depositary Shares (GWPH) stake by 29% in Q2 2017, selling an estimated $589K and leaving 13,469 shares worth $1.35M. The position accounts for 0.06% of the portfolio, ranked #350.

Airain Ltd first reported a position in GWPH in Q3 2014 and has held it in 4 quarters since. The position peaked at $2.29M in Q1 2017. 170 funds tracked by Wall St. Rank hold GWPH as of Q2 2017.

  • Airain Ltd held 13,469 shares of GW Pharmaceuticals Plc American Depositary Shares worth $1.35M as of Q2 2017.
  • Airain Ltd sold 5,472 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2017, an estimated $589K.
  • GW Pharmaceuticals Plc American Depositary Shares made up 0.06% of Airain Ltd's portfolio in Q2 2017, its #350 holding.
  • Airain Ltd first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2014 and has held it in 4 quarters since.
  • Airain Ltd's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.29M in Q1 2017.
  • 170 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.